The prognostic performance of galectin-3 in HFrEF and HFpEF is lower than other molecules such as NT-proBNP or sST2, and largely influenced by renal function [91]. Nonetheless, ACC/AHA guidelines recommend the dosage of galectin-3 for prognostic stratification of patients with chronic HF, with ...
Pulse rates were measured within 10 days after HFrEF diagnosis and echo, or at the time of discharge for those who were diagnosed while an inpatient. Pulse rate was categorized into deciles and crude and multivariable Cox proportional hazard and Poisson regression models were fit to estimate ...
Participants with HFrEF trended toward higher odds of being aware of their HF diagnosis (OR 1.20 95%CI[0.73-1.98]) while less than high school education (OR 0.79 95%CI[0.39-1.61]) and living in a high poverty zip code (OR 0.57 95%CI[0.31-1.04]) were associated with a trend toward ...